[Experimental cancer of the cervix uteri in the mouse under the influence of norhydroxyprogesterone-capronate].
D000818:Animals; D002208:Caproates; D002277:Carcinoma / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D002455:Cell Division / Q000187:drug effects*; D002471:Cell Transformation, Neoplastic / Q000188:drug therapy*; D004247:DNA / Q000032:analysis; D004347:Drug Interactions; D005260:Female; D006908:Hydroxyprogesterones / Q000494:pharmacology*; D008748:Methylcholanthrene; D051379:Mice; D008815:Mice, Inbred Strains; D008858:Microscopy, Phase-Contrast; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology; D010783:Photometry; D011123:Polyploidy / Q000187:drug effects; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D014626:Vaginal Smears
D002208:Caproates; D006908:Hydroxyprogesterones; D008748:Methylcholanthrene; D004247:DNA
Das experimentelle Portiokarzinom der Maus unter der Einwirkung von Norhydroxyprogesteroncapronat.